synergy nash tirzepatide Post-hoc analysis of SYNERGY-NASH trial reveals key insights on #tirzepatide in #MASH patients ✓ MASH resolution linked to greater weight loss (-16% vs -7%) ✓ Fibrosis improvement associated with better glycemic control Tirzepatide: A Promising Drug for

Safe and Weight Neutral: DPP-4 inhibitors do not cause weight gain, which is an advantage for the elderly who may already be metabolically challenged compared to sulfonylureas and insulin

Seek medical advice if hiccups persist for more than 48 hours, interfere with daily activities, or occur alongside severe abdominal pain, persistent vomiting, breathing difficulties, or signs of dehydration

Wellbutrin XL contains the active ingredient bupropion hydrochloride

Malyszczak A, Przezdziecka-Dolyk J, Szydelko-Pasko U, Misiuk-Hojlo M

Oral Carnitine may also improve muscle weakness

Additionally, Wellbutrin may have other interactions that could affect you